Year |
Citation |
Score |
2020 |
Pinkhardt EH, Ding Y, Slotnick S, Kassubek J, Ludolph AC, Glazman S, Selesnick I, Bodis-Wollner I. The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 32676747 DOI: 10.1007/S00702-020-02224-9 |
0.387 |
|
2017 |
Chou KL, Elm JJ, Wielinski CL, Simon DK, Aminoff MJ, Christine CW, Liang GS, Hauser RA, Sudarsky L, Umeh CC, Voss T, Juncos J, Fang JY, Boyd JT, Bodis-Wollner I, et al. Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort. Journal of the Neurological Sciences. 377: 137-143. PMID 28477684 DOI: 10.1016/J.Jns.2017.04.011 |
0.331 |
|
2016 |
Hauser RA, Li R, Pérez A, Ren X, Weintraub D, Elm J, Goudreau JL, Morgan JC, Fang JY, Aminoff MJ, Christine CW, Dhall R, Umeh CC, Boyd JT, Stover N, ... ... Bodis-Wollner I, et al. Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1. Journal of Parkinson's Disease. PMID 27911341 DOI: 10.3233/Jpd-160965 |
0.327 |
|
2016 |
Wills AA, Elm JJ, Ye R, Chou KL, Parashos SA, Hauser RA, Bodis-Wollner I, Hinson VK, Christine CW, Schneider JS. Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1. Parkinsonism & Related Disorders. PMID 27743701 DOI: 10.1016/J.Parkreldis.2016.10.005 |
0.32 |
|
2016 |
Miri S, Chopra P, Glazman S, Mylin L, Bodis-Wollner I. 5. Visual evoked potentials, contrast sensitivity and foveal optical coherence tomography in Parkinson’s disease patients Clinical Neurophysiology. 127: e161-e162. DOI: 10.1016/J.Clinph.2015.10.056 |
0.401 |
|
2015 |
Miri S, Glazman S, Mylin L, Bodis-Wollner I. A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease. Parkinsonism & Related Disorders. PMID 26414119 DOI: 10.1016/J.Parkreldis.2015.09.015 |
0.424 |
|
2015 |
Balazs S, Kermanshahi K, Binder H, Rattay F, Bodis-Wollner I. Gamma-Band Modulation and Coherence in the EEG by Involuntary Eye Movements in Patients in Unresponsive Wakefulness Syndrome. Clinical Eeg and Neuroscience. PMID 26346965 DOI: 10.1177/1550059415601756 |
0.321 |
|
2015 |
Westheimer O, McRae C, Henchcliffe C, Fesharaki A, Glazman S, Ene H, Bodis-Wollner I. Dance for PD: a preliminary investigation of effects on motor function and quality of life among persons with Parkinson's disease (PD). Journal of Neural Transmission (Vienna, Austria : 1996). PMID 25836752 DOI: 10.1007/S00702-015-1380-X |
0.322 |
|
2015 |
Miri S, Shrier EM, Glazman S, Ding Y, Selesnick I, Kozlowski PB, Bodis-Wollner I. The avascular zone and neuronal remodeling of the fovea in Parkinson disease. Annals of Clinical and Translational Neurology. 2: 196-201. PMID 25750923 DOI: 10.1002/Acn3.146 |
0.307 |
|
2015 |
Fang JY, Pérez A, Christine CW, Leehey M, Aminoff MJ, Boyd JT, Morgan JC, Dhall R, Nicholas AP, Bodis-Wollner I, Zweig RM, Goudreau JL. Parkinson's disease severity and use of dopaminergic medications. Parkinsonism & Related Disorders. 21: 297-9. PMID 25541182 DOI: 10.1016/J.Parkreldis.2014.10.016 |
0.318 |
|
2015 |
Sabari JS, Ortiz D, Pallatto K, Yagerman J, Glazman S, Bodis-Wollner I. Activity engagement and health quality of life in people with Parkinson's disease. Disability and Rehabilitation. 37: 1411-5. PMID 25332087 DOI: 10.3109/09638288.2014.972588 |
0.301 |
|
2014 |
Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. Jama Neurology. 71: 710-6. PMID 24711047 DOI: 10.1001/Jamaneurol.2014.391 |
0.312 |
|
2014 |
Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, ... ... Bodis-Wollner I, et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. Jama Neurology. 71: 543-52. PMID 24664227 DOI: 10.1001/Jamaneurol.2014.131 |
0.306 |
|
2013 |
Adam CR, Shrier E, Ding Y, Glazman S, Bodis-Wollner I. Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 33: 137-42. PMID 23612240 DOI: 10.1097/Wno.0B013E31828C4E1A |
0.392 |
|
2013 |
Bodis-Wollner I, Glazman S, Yerram S. Fovea and foveation in Parkinson's disease. Behavioral Neuroscience. 127: 139-50. PMID 23356330 DOI: 10.1037/A0031225 |
0.414 |
|
2013 |
Bodis-Wollner I. Foveal vision is impaired in Parkinson's disease. Parkinsonism & Related Disorders. 19: 1-14. PMID 22998939 DOI: 10.1016/J.Parkreldis.2012.07.012 |
0.44 |
|
2013 |
Yerram S, Glazman S, Bodis-Wollner I. Cortical control of saccades in Parkinson disease and essential tremor. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 145-56. PMID 22926662 DOI: 10.1007/S00702-012-0870-3 |
0.355 |
|
2013 |
Javaid M, Lafontaine A, Glazman S, Bodis-Wollner I. 3. Perisaccadic EEG components in Parkinson disease patients Clinical Neurophysiology. 124: e6. DOI: 10.1016/J.Clinph.2012.08.031 |
0.367 |
|
2012 |
Shrier EM, Adam CR, Spund B, Glazman S, Bodis-Wollner I. Interocular asymmetry of foveal thickness in Parkinson disease. Journal of Ophthalmology. 2012: 728457. PMID 22900149 DOI: 10.1155/2012/728457 |
0.38 |
|
2012 |
Javaid MA, Amassian V, Glazman S, Fesharaki A, Stefanov D, Bodis-Wollner I. Cortical control of voluntary saccades in Parkinson's disease and pre-emptive perception. Parkinsonism & Related Disorders. 18: S100-3. PMID 22166401 DOI: 10.1016/S1353-8020(11)70032-3 |
0.384 |
|
2012 |
Bodis-Wollner I, Javaid M, Glazman S. 2.2.2 FRONTO-PARIETAL COHERENCE AND IMPAIRED VOLUNTARY SACCADES IN PARKINSON DISEASE (PD) Parkinsonism & Related Disorders. 18: S82. DOI: 10.1016/S1353-8020(11)70393-5 |
0.372 |
|
2011 |
Chou KL, Zamudio J, Schmidt P, Price CC, Parashos SA, Bloem BR, Lyons KE, Christine CW, Pahwa R, Bodis-Wollner I, Oertel WH, Suchowersky O, Aminoff MJ, Malaty IA, Friedman JH, et al. Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers. Parkinsonism & Related Disorders. 17: 440-5. PMID 21458353 DOI: 10.1016/J.Parkreldis.2011.03.002 |
0.3 |
|
2010 |
Javaid MA, Weeden J, Flom P, Avitable M, Glazman S, Bodis-Wollner I. Perisaccadic gamma modulation in Parkinson disease patients and healthy subjects. Clinical Eeg and Neuroscience. 41: 94-101. PMID 20521492 DOI: 10.1177/155005941004100209 |
0.371 |
|
2010 |
Bodis-Wollner I. Current aspects of cognitive neurophysiology of Parkinson disease: an introduction. Clinical Eeg and Neuroscience. 41: 68-75. PMID 20521488 DOI: 10.1177/155005941004100205 |
0.337 |
|
2010 |
Rieger JW, Bodis-Wollner I, Schoenfeld MA, Heinze H. Differences in perisaccadic retinotopic and spatiotopic localization in the parietal and occipital cortices in the absence of visual input Journal of Vision. 6: 504-504. DOI: 10.1167/6.6.504 |
0.352 |
|
2009 |
Bodis-Wollner I. Retinopathy in Parkinson Disease. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 1493-501. PMID 19730784 DOI: 10.1007/S00702-009-0292-Z |
0.439 |
|
2009 |
Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC, Shulman LM. Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Archives of Neurology. 66: 1099-104. PMID 19597081 DOI: 10.1001/Archneurol.2009.159 |
0.327 |
|
2009 |
Bodis-Wollner I, Brannan JR, Storch RL, Hajee ME, Minko M. The effect of background spatial contrast on electroretinographic responses in the human retina. Vision Research. 49: 922-30. PMID 18723047 DOI: 10.1016/J.Visres.2008.07.008 |
0.347 |
|
2008 |
Rieger JW, Kim A, Argyelan M, Farber M, Glazman S, Liebeskind M, Meyer T, Bodis-Wollner I. Cortical functional anatomy of voluntary saccades in Parkinson disease. Clinical Eeg and Neuroscience. 39: 169-74. PMID 19044213 DOI: 10.1177/155005940803900404 |
0.385 |
|
2008 |
Rieger JW, Schoenfeld MA, Heinze HJ, Bodis-Wollner I. Different spatial organizations of saccade related BOLD-activation in parietal and striate cortex. Brain Research. 1233: 89-97. PMID 18710650 DOI: 10.1016/J.Brainres.2008.07.108 |
0.355 |
|
2008 |
Antal A, Terney D, Bodis-Wollner I. Parkinson's disease, aging, and visual cognition Topics in Geriatric Rehabilitation. 24: 166-181. DOI: 10.1097/01.Tgr.0000318903.80066.E7 |
0.361 |
|
2006 |
Forgacs PB, Von Gizycki H, Harhula M, Avitable M, Selesnick I, Bodis-Wollner I. The wavelet transformed EEG: a new method of trial-by-trial evaluation of saccade-related cortical activity. Supplements to Clinical Neurophysiology. 59: 183-9. PMID 16893110 DOI: 10.1016/S1567-424X(09)70029-7 |
0.314 |
|
2004 |
Forgacs PB, Bodis-Wollner I. Nicotinic receptors and cognition in Parkinson's Disease: the importance of neuronal synchrony. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 1317-31. PMID 15480841 DOI: 10.1007/S00702-004-0169-0 |
0.314 |
|
2003 |
Bodis-Wollner I. Neuropsychological and perceptual defects in Parkinson's disease. Parkinsonism & Related Disorders. 9: S83-9. PMID 12915072 DOI: 10.1016/S1353-8020(03)00022-1 |
0.412 |
|
2002 |
Bodis-Wollner I. Visualizing the next steps in Parkinson disease. Archives of Neurology. 59: 1233-4. PMID 12164717 DOI: 10.1001/Archneur.59.8.1233 |
0.397 |
|
2002 |
Sartucci F, Tagliati M, Mylin LH, Bodis-Wollner I. Topographical analysis of the onset VEP in the detection of paracentral visual field defects. Clinical Eeg (Electroencephalography). 33: 62-9. PMID 12025733 DOI: 10.1177/155005940203300204 |
0.636 |
|
2002 |
Antal A, Kéri S, Dibó G, Benedek G, Janka Z, Vécsei L, Bodis-Wollner I. Electrophysiological correlates of visual categorization: evidence for cognitive dysfunctions in early Parkinson's disease. Brain Research. Cognitive Brain Research. 13: 153-8. PMID 11958957 DOI: 10.1016/S0926-6410(01)00090-8 |
0.449 |
|
2002 |
Bandini F, Pierantozzi M, Bodis-Wollner I. The visuo-cognitive and motor effect of amantadine in non-Caucasian patients with Parkinson's disease. A clinical and electrophysiological study. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 41-51. PMID 11793161 DOI: 10.1007/S702-002-8235-5 |
0.426 |
|
2001 |
Bodis-Wollner I, Davis J, Tzelepi A, Bezerianos T. Wavelet transform of the EEG reveals differences in low and high gamma responses to elementary visual stimuli. Clinical Eeg (Electroencephalography). 32: 139-44. PMID 11512377 DOI: 10.1177/155005940103200308 |
0.372 |
|
2001 |
Bandini F, Pierantozzi M, Bodis-Wollner I. Parkinson's disease changes the balance of onset and offset visual responses: an evoked potential study. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 112: 976-83. PMID 11377254 DOI: 10.1016/S1388-2457(01)00531-4 |
0.457 |
|
2001 |
Mari Z, Sagliocco L, Bodis-Wollner I. Retinocortical gain in the foveal pathway: the effect of spatial frequency and stimulus size. Clinical Eeg (Electroencephalography). 32: 67-74. PMID 11360723 DOI: 10.1177/155005940103200205 |
0.358 |
|
2001 |
Antal A, Aita JF, Bodis-Wollner I. The paracentral visual field in multiple sclerosis: evidence for a deficit in interneuronal spatial summation? Vision Research. 41: 1735-42. PMID 11348654 DOI: 10.1016/S0042-6989(01)00051-7 |
0.399 |
|
2000 |
Bodis-Wollner I, Brannan JR. Psychophysical examination of paracentral defects in glaucoma. Current Opinion in Ophthalmology. 11: 140-4. PMID 10848221 DOI: 10.1097/00055735-200004000-00013 |
0.355 |
|
2000 |
Tzelepi A, Bezerianos T, Bodis-Wollner I. Functional properties of sub-bands of oscillatory brain waves to pattern visual stimulation in man. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 111: 259-69. PMID 10680560 DOI: 10.1016/S1388-2457(99)00248-5 |
0.384 |
|
1999 |
Bodis-Wollner I, Bucher SF, Seelos KC. Cortical activation patterns during voluntary blinks and voluntary saccades. Neurology. 53: 1800-5. PMID 10563631 DOI: 10.1212/Wnl.53.8.1800 |
0.337 |
|
1999 |
Bodis-Wollner IG, Paulus W. Visual and visual cognitive dysfunction in Parkinson's disease: spatial and chromatic vision. Advances in Neurology. 80: 383-8. PMID 10410745 |
0.31 |
|
1999 |
Stanzione P, Bodis-Wollner I, Pierantozzi M, Semprini R, Tagliati M, Peppe A, Bernardi G. A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 110: 82-5. PMID 10348324 DOI: 10.1016/S0168-5597(98)00047-1 |
0.49 |
|
1998 |
Bodis-Wollner I, Tzelepi A. The push-pull action of dopamine on spatial tuning of the monkey retina: the effects of dopaminergic deficiency and selective D1 and D2 receptor ligands on the pattern electroretinogram. Vision Research. 38: 1479-87. PMID 9667012 DOI: 10.1016/S0042-6989(98)00028-5 |
0.332 |
|
1998 |
Peppe A, Antal A, Tagliati M, Stanzione P, Bodis-Wollner I. D1 agonist CY208-243 attenuates the pattern electroretinogram to low spatial frequency stimuli in the monkey. Neuroscience Letters. 243: 5-8. PMID 9535099 DOI: 10.1016/S0304-3940(98)00068-8 |
0.306 |
|
1997 |
Antal A, Kéri S, Bodis-Wollner I. Dopamine D2 receptor blockade alters the primary and cognitive components of visual evoked potentials in the monkey, Macaca fascicularis. Neuroscience Letters. 232: 179-81. PMID 9310309 DOI: 10.1016/S0304-3940(97)00596-X |
0.341 |
|
1997 |
Sagliocco L, Bandini F, Pierantozzi M, Mari Z, Tzelepi A, Ko C, Gulzar J, Bodis-Wollner I. Electrophysiological evidence for visuocognitive dysfunction in younger non Caucasian patients with Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 104: 427-39. PMID 9295175 DOI: 10.1007/Bf01277661 |
0.445 |
|
1997 |
Bodis-Wollner I, Brannan JR. Hidden visual loss in optic neuropathy is revealed using Gabor patch contrast perimetry. Clinical Neuroscience (New York, N.Y.). 4: 284-91. PMID 9292257 |
0.343 |
|
1997 |
Bodis-Wollner I, Bucher SF, Seelos KC, Paulus W, Reiser M, Oertel WH. Functional MRI mapping of occipital and frontal cortical activity during voluntary and imagined saccades. Neurology. 49: 416-20. PMID 9270570 DOI: 10.1212/Wnl.49.2.416 |
0.326 |
|
1997 |
Bodis-Wollner I. Visual electrophysiology in Parkinson's disease: PERG, VEP and visual P300. Clinical Eeg (Electroencephalography). 28: 143-7. PMID 9241467 DOI: 10.1177/155005949702800305 |
0.479 |
|
1996 |
Antal A, Pfeiffer R, Bodis-Wollner I. Simultaneously evoked primary and cognitive visual evoked potentials distinguish younger and older patients with Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 103: 1053-67. PMID 9013393 DOI: 10.1007/BF01291790 |
0.344 |
|
1996 |
Tagliati M, Bodis-Wollner I, Yahr MD. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. Electroencephalography and Clinical Neurophysiology. 100: 1-11. PMID 8964257 DOI: 10.1016/0168-5597(95)00169-7 |
0.424 |
|
1995 |
Bodis-Wollner I, Borod JC, Cicero B, Haywood CS, Raskin S, Mylin L, Sliwinski M, Falk A, Yahr MD. Modality dependent changes in event-related potentials correlate with specific cognitive functions in nondemented patients with Parkinson's disease. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 9: 197-209. PMID 8527004 DOI: 10.1007/BF02259661 |
0.348 |
|
1995 |
van Paesschen W, Mylin LH, Tagliati M, Sherman J, Bodis-Wollner I. Syphilitic perioptic neuritis in an HIV-seropositive patient: A case report and VEP study Neuro-Ophthalmology. 15: 271-275. DOI: 10.3109/01658109509044614 |
0.343 |
|
1994 |
Antal A, Kovanecz I, Bodis-Wollner I. Visual discrimination and P300 are affected in parallel by cholinergic agents in the behaving monkey. Physiology & Behavior. 56: 161-6. PMID 8084895 DOI: 10.1016/0031-9384(94)90274-7 |
0.389 |
|
1994 |
Tagliati M, Bodis-Wollner I, Kovanecz I, Stanzione P. Spatial frequency tuning of the monkey pattern ERG depends on D2 receptor-linked action of dopamine. Vision Research. 34: 2051-7. PMID 7941404 DOI: 10.1016/0042-6989(94)90316-6 |
0.366 |
|
1994 |
Bodis-Wollner I, Brannan JR. Assessment of Current visual psycho-physical testing methods with special reference to primary open angle glaucomatous disease (POAGD) Neuro-Ophthalmology. 14: 61-71. DOI: 10.3109/01658109409019488 |
0.405 |
|
1994 |
Sherman J, Bodis-Wollner I, Howell N. VISUAL FUNCTION IMPROVEMENT WITH EXPERIMENTAL THERAPY IN MITOCHON DRIAL OPTIC NEUROPATHY Optometry and Vision Science. 71: 114. DOI: 10.1097/00006324-199412001-00231 |
0.309 |
|
1993 |
Antal A, Bodis-Wollner I, Ghilardi MF, Glover A, Mylin L, Toldi J. The effect of levo-acetyl-carnitine on visual cognitive evoked potentials in the behaving monkey. Electroencephalography and Clinical Neurophysiology. 86: 268-74. PMID 7682930 DOI: 10.1016/0013-4694(93)90108-8 |
0.374 |
|
1993 |
Celesia GG, Bodis-Wollner I, Chatrian GE, Harding GF, Sokol S, Spekreijse H. Recommended standards for electroretinograms and visual evoked potentials. Report of an IFCN committee. Electroencephalography and Clinical Neurophysiology. 87: 421-36. PMID 7508376 DOI: 10.1016/0013-4694(93)90157-Q |
0.382 |
|
1993 |
Bodis-Wollner I, Sartucci F, Mylin L, Tagliati M. The clinical use of multichannel VEP recordings in detecting visual field defects Electroencephalography and Clinical Neurophysiology. 87: S55. DOI: 10.1016/0013-4694(93)91087-H |
0.349 |
|
1992 |
Tagliati M, Brannan JR, Bodis-Wollner I. Contrast sensitivity in PD. Neurology. 42: 1126-7. PMID 1579246 DOI: 10.1212/Wnl.42.5.1126 |
0.327 |
|
1992 |
Bodis-Wollner I, Brannan JR, Nicoll J, Frkovic S, Mylin LH. A short latency cortical component of the foveal VEP is revealed by hemifield stimulation. Electroencephalography and Clinical Neurophysiology. 84: 201-8. PMID 1375879 DOI: 10.1016/0168-5597(92)90001-R |
0.371 |
|
1991 |
Glover A, Ghilardi MF, Bodis-Wollner I, Onofrj M, Mylin LH. Visual 'cognitive' evoked potentials in the behaving monkey. Electroencephalography and Clinical Neurophysiology. 80: 65-72. PMID 1703952 DOI: 10.1016/0168-5597(91)90045-Y |
0.362 |
|
1991 |
Ghilardi MF, Sartucci F, Brannan JR, Onofrj MC, Bodis-Wollner I, Mylin L, Stroch R. N70 and P100 can be independently affected in multiple sclerosis. Electroencephalography and Clinical Neurophysiology. 80: 1-7. PMID 1703943 DOI: 10.1016/0168-5597(91)90035-V |
0.313 |
|
1990 |
Raskin SA, Borod JC, Wasserstein J, Bodis-Wollner I, Coscia L, Yahr MD. Visuospatial orientation in Parkinson's disease. The International Journal of Neuroscience. 51: 9-18. PMID 2265914 DOI: 10.3109/00207459009000503 |
0.371 |
|
1990 |
Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends in Neurosciences. 13: 296-302. PMID 1695407 DOI: 10.1016/0166-2236(90)90113-O |
0.409 |
|
1990 |
Glover A, Ghilardi M, Bodis-Wollner I. Visual and cognitive ERPs in trained monkeys Electroencephalography and Clinical Neurophysiology. 75: S50-S51. DOI: 10.1016/0013-4694(90)91901-Z |
0.31 |
|
1989 |
Bodis-Wollner I. Electrophysiological and psychophysical testing of vision in glaucoma. Survey of Ophthalmology. 33: 301-7. PMID 2655143 |
0.34 |
|
1989 |
Berardi N, Bodis-Wollner I, Fiorentini A, Giuffré G, Morelli M. Electrophysiological evidence for interhemispheric transmission of visual information in man. The Journal of Physiology. 411: 207-25. PMID 2614724 DOI: 10.1113/jphysiol.1989.sp017569 |
0.322 |
|
1989 |
Ghilardi MF, Marx MS, Bodis-Wollner I, Camras CB, Glover AA. The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Annals of Neurology. 25: 357-64. PMID 2496639 DOI: 10.1002/ana.410250407 |
0.324 |
|
1988 |
Marx MS, Podos SM, Bodis-Wollner I, Lee PY, Wang RF, Severin C. Signs of early damage in glaucomatous monkey eyes: low spatial frequency losses in the pattern ERG and VEP. Experimental Eye Research. 46: 173-84. PMID 3350063 DOI: 10.1016/S0014-4835(88)80075-7 |
0.417 |
|
1988 |
Bodis-Wollner I. Visual contrast sensitivity. Neurology. 38: 336-7. PMID 3340311 DOI: 10.1212/Wnl.38.2.336 |
0.374 |
|
1988 |
Ghilardi MF, Chung E, Bodis-Wollner I, Dvorzniak M, Glover A, Onofrj M. Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. Life Sciences. 43: 255-62. PMID 3260986 DOI: 10.1016/0024-3205(88)90315-3 |
0.352 |
|
1988 |
Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover AA. Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain : a Journal of Neurology. 111: 131-49. PMID 3259150 DOI: 10.1093/Brain/111.1.131 |
0.47 |
|
1988 |
Bobak P, Bodis-Wollner I, Marx MS. Cortical contrast gain control in human spatial vision. The Journal of Physiology. 405: 421-37. PMID 3255797 DOI: 10.1113/Jphysiol.1988.Sp017340 |
0.334 |
|
1988 |
Glover A, Ghilardi MF, Bodis-Wollner I, Onofrj M. Alterations in event-related potentials (ERPs) of MPTP-treated monkeys. Electroencephalography and Clinical Neurophysiology. 71: 461-8. PMID 2460327 DOI: 10.1016/0168-5597(88)90050-0 |
0.363 |
|
1987 |
Marx MS, Bodis-Wollner I, Lustgarten JS, Podos SM. Electrophysiological evidence that early glaucoma affects foveal vision. Documenta Ophthalmologica. Advances in Ophthalmology. 67: 281-301. PMID 3447853 DOI: 10.1007/Bf00144282 |
0.388 |
|
1987 |
Ghilardi MF, Marx MS, Onofrj MC, Glover AA, Bodis-Wollner I. Scalp distribution of pattern visual evoked potentials in normal and hemianopic monkeys. Physiology & Behavior. 41: 297-302. PMID 3432382 DOI: 10.1016/0031-9384(87)90391-X |
0.414 |
|
1987 |
Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain : a Journal of Neurology. 110: 1675-98. PMID 3427405 DOI: 10.1093/Brain/110.6.1675 |
0.436 |
|
1987 |
Bobak P, Bodis-Wollner I, Guillory S. The effect of blur and contrast on VEP latency: comparison between check and sinusoidal and grating patterns. Electroencephalography and Clinical Neurophysiology. 68: 247-55. PMID 2439304 DOI: 10.1016/0168-5597(87)90045-1 |
0.323 |
|
1987 |
Bodis-Wollner I, Feldman RG, Guillory SL, Mylin L. Delayed visual evoked potentials are independent of pattern orientation in macular disease. Electroencephalography and Clinical Neurophysiology. 68: 172-9. PMID 2436876 DOI: 10.1016/0168-5597(87)90024-4 |
0.434 |
|
1987 |
Bodis-Wollner I, Mylin L. Plasticity of monocular and binocular vision following cerebral blindness: evoked potential evidence. Electroencephalography and Clinical Neurophysiology. 68: 70-4. PMID 2431893 DOI: 10.1016/0168-5597(87)90071-2 |
0.396 |
|
1987 |
Cohen B, Bodis-Wollner I. Annual Meeting, Association for Research in Nervous and Mental Diseases Inc: Vision and the Brain: The Organization of the Central Visual System Archives of Neurology. 44: 1207-1211. DOI: 10.1001/Archneur.1987.00520230087024 |
0.314 |
|
1986 |
Marx MS, Podos SM, Bodis-Wollner I, Howard-Williams JR, Siegel MJ, Teitelbaum CS, Maclin EL, Severin C. Flash and pattern electroretinograms in normal and laser-induced glaucomatous primate eyes. Investigative Ophthalmology & Visual Science. 27: 378-86. PMID 3949466 |
0.661 |
|
1986 |
Marx M, Bodis-Wollner I, Bobak P, Harnois C, Mylin L, Yahr M. Temporal frequency-dependent VEP changes in Parkinson's disease. Vision Research. 26: 185-93. PMID 3716211 DOI: 10.1016/0042-6989(86)90080-5 |
0.438 |
|
1986 |
Siegel MJ, Marx MS, Bodis-Wollner I, Podos SM. The effect of refractive error on pattern electroretinograms in primates. Current Eye Research. 5: 183-7. PMID 3698651 DOI: 10.3109/02713688609020041 |
0.411 |
|
1986 |
Heyer EJ, Simpson DM, Bodis-Wollner I, Diamond SP. Nitrous oxide: clinical and electrophysiologic investigation of neurologic complications. Neurology. 36: 1618-22. PMID 3024066 DOI: 10.1212/Wnl.36.12.1618 |
0.349 |
|
1986 |
Glover AA, Onofrj MC, Ghilardi MF, Bodis-Wollner I. P300-like potentials in the normal monkey using classical conditioning and an auditory 'oddball' paradigm. Electroencephalography and Clinical Neurophysiology. 65: 231-5. PMID 2420576 DOI: 10.1016/0168-5597(86)90058-4 |
0.331 |
|
1985 |
Bodis-Wollner I. Pattern evoked potential changes in parkinson’s disease are stimulus-dependent Neurology. 35: 1675-1676. PMID 4058761 DOI: 10.1212/Wnl.35.11.1674-A |
0.345 |
|
1985 |
Onofrj M, Harnois C, Bodis-Wollner I. The hemispheric distribution of the transient rat VEP: a comparison of flash and pattern stimulation. Experimental Brain Research. 59: 427-33. PMID 4029318 DOI: 10.1007/Bf00261332 |
0.385 |
|
1985 |
Bass SJ, Sherman J, Bodis-Wollner I, Nath S. Visual evoked potentials in macular disease. Investigative Ophthalmology & Visual Science. 26: 1071-4. PMID 4019098 |
0.31 |
|
1985 |
Onofrj M, Bodis-Wollner I, Nicoll J. Stimulus specific VEP lateralization in normals and patients with hemianopias Electroencephalography and Clinical Neurophysiology. 61: S25. DOI: 10.1016/0013-4694(85)90130-0 |
0.309 |
|
1985 |
Bodis-Wollner I, Mylin L, Marx M. Abnormal contrast-dependent VEP changes in Parkinson's disease Electroencephalography and Clinical Neurophysiology. 61: S24. DOI: 10.1016/0013-4694(85)90127-0 |
0.331 |
|
1984 |
Harnois C, Bodis-Wollner I, Onofrj M. The effect of contrast and spatial frequency on the visual evoked potential of the hooded rat. Experimental Brain Research. 57: 1-8. PMID 6519219 DOI: 10.1007/Bf00231126 |
0.385 |
|
1983 |
Bobak P, Bodis-Wollner I, Harnois C, Maffei L, Mylin L, Podos S, Thornton J. Pattern electroretinograms and visual-evoked potentials in glaucoma and multiple sclerosis. American Journal of Ophthalmology. 96: 72-83. PMID 6869481 DOI: 10.1016/0002-9394(83)90457-9 |
0.45 |
|
1983 |
Bodis-Wollner I, Harnois C, Bobak P, Mylin L. On the possible role of temporal delays of afferent processing in Parkinson's disease. Journal of Neural Transmission. Supplementum. 19: 243-52. PMID 6321648 |
0.308 |
|
1982 |
Onofrj M, Bodis-Wollner I. Dopaminergic deficiency causes delayed visual evoked potentials in rats. Annals of Neurology. 11: 484-90. PMID 7103424 DOI: 10.1002/Ana.410110508 |
0.356 |
|
1982 |
Onofrj M, Bodis-Wollner I, Bobak P. Pattern visual evoked potentials in the rat. Physiology & Behavior. 28: 227-30. PMID 7079334 DOI: 10.1016/0031-9384(82)90066-X |
0.412 |
|
1982 |
Onofrj M, Bodis-Wollner I, Mylin L. Visual evoked potential diagnosis of field defects in patients with chiasmatic and retrochiasmatic lesions. Journal of Neurology, Neurosurgery, and Psychiatry. 45: 294-302. PMID 7077338 DOI: 10.1136/Jnnp.45.4.294 |
0.404 |
|
1982 |
Camisa J, Bodis-Wollner I. Stimulus parameters and visual evoked potential diagnosis. Annals of the New York Academy of Sciences. 388: 645-7. PMID 6953896 DOI: 10.1111/J.1749-6632.1982.Tb50828.X |
0.362 |
|
1981 |
Bodis-Wollner I, Barris MC, Mylin LH, Julesz B, Kropfl W. Binocular stimulation reveals cortical components of the human visual evoked potential. Electroencephalography and Clinical Neurophysiology. 52: 298-305. PMID 6169506 DOI: 10.1016/0013-4694(81)90058-4 |
0.362 |
|
1981 |
Onofrj M, Bodis-Wollner I, Mylin L. Visual evoked potential latencies in papilledema and hydrocephalus Neuro-Ophthalmology. 2: 85-92. DOI: 10.3109/01658108109004926 |
0.389 |
|
1980 |
Braddick O, Atkinson J, Julesz B, Kropfl W, Bodis-Wollner I, Raab E. Cortical binocularity in infants. Nature. 288: 363-5. PMID 7432532 DOI: 10.1038/288363A0 |
0.362 |
|
1980 |
Atkin A, Wolkstein M, Bodis-Wollner I, Anders M, Kels B, Podos SM. Interocular comparison of contrast sensitivities in glaucoma patients and suspects. The British Journal of Ophthalmology. 64: 858-62. PMID 7426557 DOI: 10.1136/Bjo.64.11.858 |
0.399 |
|
1980 |
Wolkstein M, Atkin A, Bodis-Wollner I. Contrast sensitivity in retinal disease. Ophthalmology. 87: 1140-9. PMID 7243206 DOI: 10.1016/S0161-6420(80)35112-9 |
0.396 |
|
1979 |
Atkin A, Bodis-Wollner I, Wolkstein M, Moss A, Podos SM. Abnormalities of central contrast sensitivity in glaucoma. American Journal of Ophthalmology. 88: 205-11. PMID 474692 DOI: 10.1016/0002-9394(79)90467-7 |
0.408 |
|
1978 |
Bodis-Wollner I, Yahr MD. Measurements of visual evoked potentials in Parkinson's disease. Brain : a Journal of Neurology. 101: 661-71. PMID 737524 DOI: 10.1093/brain/101.4.661 |
0.341 |
|
1977 |
Bodis-Wollner I, Atkin A, Raab E, Wolkstein M. Visual association cortex and vision in man: pattern-evoked occipital potentials in a blind boy. Science (New York, N.Y.). 198: 629-31. PMID 918658 DOI: 10.1126/Science.918658 |
0.414 |
|
1977 |
Bodis-Wollner I. Recovery from cerebral blindness: evoked potential and psychophysical measurements. Electroencephalography and Clinical Neurophysiology. 42: 178-84. PMID 65253 DOI: 10.1016/0013-4694(77)90024-4 |
0.337 |
|
1976 |
Bodis-Wollner I. Vulnerability of spatial frequency channels in cerebral lesions. Nature. 261: 309-11. PMID 1272403 DOI: 10.1038/261309A0 |
0.382 |
|
1976 |
Bodis-Wollner I, Diamond SP. The measurement of spatial contrast sensitivity in cases of blurred vision associated with cerebral lesions. Brain : a Journal of Neurology. 99: 695-710. PMID 1030654 DOI: 10.1093/Brain/99.4.695 |
0.406 |
|
1975 |
Bodis-Wollner I. Letter: Visual acuity measurements with grating patterns. Lancet. 2: 503-4. PMID 51316 DOI: 10.1016/S0140-6736(75)90579-6 |
0.397 |
|
1972 |
Bodis-Wollner I. Visual acuity and contrast sensitivity in patients with cerebral lesions. Science (New York, N.Y.). 178: 769-71. PMID 5082844 DOI: 10.1126/Science.178.4062.769 |
0.378 |
|
1972 |
Bodis-Wollner I, Hendley CD, Kulikowski JJ. Electrophysiological and psychophysical responses to modulation of contrast of a grating pattern. Perception. 1: 341-9. PMID 4680937 DOI: 10.1068/P010341 |
0.624 |
|
Low-probability matches (unlikely to be authored by this person) |
1997 |
Bandini F, Pierantozzi M, Sagliocco L, Bodis-Wollner I. Simultaneously evoked primary and cognitive visual evoked potentials reveal visuocognitive dysfunction in younger patients with Parkinson's Disease Italian Journal of Neurological Sciences. 18: 134. |
0.3 |
|
1980 |
Bodis-Wollner I. Detection of visual defects using the contrast sensitivity function. International Ophthalmology Clinics. 20: 135-53. PMID 6995374 DOI: 10.1097/00004397-198002010-00007 |
0.299 |
|
1982 |
Bodis-Wollner I. Roundtable session: the true binocular visual evoked potential: introduction. Annals of the New York Academy of Sciences. 388: 608-9. PMID 6953890 DOI: 10.1111/j.1749-6632.1982.tb50820.x |
0.296 |
|
1977 |
Friedland RP, Bodis-Wollner I. Absence of somatosensory evoked potentials in patients with anosognosia. Neurology. 27: 695-7. PMID 559980 DOI: 10.1212/Wnl.27.7.695-A |
0.295 |
|
2011 |
Amassian VE, Cracco RQ, MacCabee PJ, Cracco JB, Rudell AP, Eberle L, Bodis-Wollner I. The role of visual perception in spoken responses Biocybernetics and Biomedical Engineering. 31: 65-80. DOI: 10.1016/S0208-5216(11)70020-1 |
0.294 |
|
2011 |
Aminoff MJ, Christine CW, Friedman JH, Chou KL, Lyons KE, Pahwa R, Bloem BR, Parashos SA, Price CC, Malaty IA, Iansek R, Bodis-Wollner I, Suchowersky O, Oertel WH, Zamudio J, et al. Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism & Related Disorders. 17: 139-45. PMID 21159538 DOI: 10.1016/J.Parkreldis.2010.11.009 |
0.288 |
|
1993 |
Bodis-Wollner I, Tagliati M. The visual system in Parkinson's disease. Advances in Neurology. 60: 390-4. PMID 8420159 |
0.286 |
|
1990 |
Bodis-Wollner I. The visual system in Parkinson's disease. Research Publications - Association For Research in Nervous and Mental Disease. 67: 297-316. PMID 2106154 |
0.286 |
|
1987 |
Bodis-Wollner I, Onofrj M. The visual system in Parkinson's disease. Advances in Neurology. 45: 323-7. PMID 3103388 |
0.286 |
|
2015 |
Simuni T, Kieburtz K, Tilley B, J Elm J, Ravina B, Babcock D, Emborg M, Hauser R, Kamp C, Morgan JC, Webster Ross G, K Simon D, Bainbridge J, Baker L, Bodis-Wollner I, et al. Pioglitazone in early Parkinson's disease: A phase 2, multicentre, double-blind, randomised trial The Lancet Neurology. 14: 795-803. DOI: 10.1016/S1474-4422(15)00144-1 |
0.285 |
|
1993 |
Bodis-Wollner I, Tagliati M, Peppe A, Antal A. Visual and visual perceptual disorders in neurodegenerative diseases. Bailliã¨Re's Clinical Neurology. 2: 461-91. PMID 8137009 |
0.284 |
|
1992 |
Brannan JR, Bodis-Wollner I, Storch RL. Evidence for two distinct nonlinear components in the human pattern ERG. Vision Research. 32: 11-7. PMID 1502796 DOI: 10.1016/0042-6989(92)90107-T |
0.284 |
|
1973 |
Bodis-Wollner I, Bodis-Wollner I. A distractive effect of peripheral attention on foveal trigram recognition. Perception. 2: 407-13. PMID 4803949 DOI: 10.1068/P020407 |
0.282 |
|
2010 |
Bodis-Wollner I. Cognitive neurophysiology of Parkinson disease. Clinical Eeg and Neuroscience. 41: VI. PMID 20521486 DOI: 10.1177/155005941004100203 |
0.28 |
|
1998 |
Antal A, Bandini F, Kéri S, Bodis-Wollner I. Visuo-cognitive dysfunctions in Parkinson's disease. Clinical Neuroscience (New York, N.Y.). 5: 147-52. PMID 10785841 |
0.28 |
|
2014 |
Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S. α-synuclein in the inner retina in parkinson disease. Annals of Neurology. 75: 964-6. PMID 24816946 DOI: 10.1002/ana.24182 |
0.276 |
|
1978 |
Bodis-Wollner I, Hendley CD, Mylin L, Thorton J. Visual evoked potential latency changes and losses of grating pattern detection in multiple sclerosis. Transactions of the American Neurological Association. 103: 163-5. PMID 757047 |
0.276 |
|
2006 |
Bodis-Wollner I, Jo MY. Getting around and communicating with the environment: visual cognition and language in Parkinson's disease. Journal of Neural Transmission. Supplementum. 333-8. PMID 17017549 DOI: 10.1007/978-3-211-45295-0_50 |
0.274 |
|
1990 |
Aine CJ, Bodis-Wollner I, George JS. Generators of visually evoked neuromagnetic responses. Spatial-frequency segregation and evidence for multiple sources. Advances in Neurology. 54: 141-55. PMID 2270800 |
0.274 |
|
1984 |
Bobak P, Bodis-Wollner I, Harnois C, Thornton J. VEPs in humans reveal high and low spatial contrast mechanisms. Investigative Ophthalmology & Visual Science. 25: 980-3. PMID 6746236 |
0.273 |
|
1990 |
Pang S, Borod JC, Hernandez A, Bodis-Wollner I, Raskin S, Mylin L, Coscia L, Yahr MD. The auditory P 300 correlates with specific cognitive deficits in Parkinson's disease. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 2: 249-64. PMID 2078307 DOI: 10.1007/BF02252920 |
0.271 |
|
1981 |
Camisa J, Mylin LH, Bodis-Wollner I. The effect of stimulus orientation on the visual evoked potential in multiple sclerosis. Annals of Neurology. 10: 532-9. PMID 7325602 DOI: 10.1002/ana.410100607 |
0.27 |
|
2013 |
Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, Bodis-Wollner I. Remodeling of the fovea in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 745-53. PMID 23263598 DOI: 10.1007/S00702-012-0909-5 |
0.269 |
|
1995 |
Bodis-Wollner I. WS-11-4 The electroretinogram in the evaluation of dopaminergic deficiency affecting the visual system: Parkinson's disease and the effects of drugs on the retina Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control. 97: S35. DOI: 10.1016/0924-980X(95)92539-X |
0.265 |
|
1993 |
Sherman J, Bodis-Wollner I, Milch F, Goldstein J, Brannan J. Retinal periphlebitis in multiple sclerosis. Journal of the American Optometric Association. 64: 475-8. PMID 8376716 |
0.262 |
|
2003 |
Vallines I, Bodis-Wollner I, Oezyurt J, Rutschmann RM, Greenlee MW. Perisaccadic V1 activity is not due to shifting visuo-spatial attention Journal of Vision. 3: 42a. DOI: 10.1167/3.9.42 |
0.262 |
|
1980 |
Bodis-Wollner I, Korczyn AD. Dissociated sensory loss and visual evoked potentials in a patient with pernicious anemia. The Mount Sinai Journal of Medicine, New York. 47: 579-82. PMID 6971993 |
0.257 |
|
2014 |
Ding Y, Spund B, Glazman S, Shrier EM, Miri S, Selesnick I, Bodis-Wollner I. Application of an OCT data-based mathematical model of the foveal pit in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 1367-76. PMID 24748549 DOI: 10.1007/S00702-014-1214-2 |
0.251 |
|
1982 |
Bodis-Wollner I, Yahr MD, Mylin L, Thornton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Annals of Neurology. 11: 478-83. PMID 6125124 DOI: 10.1002/ana.410110507 |
0.248 |
|
2009 |
Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, Bodis-Wollner IG. Inner retinal layer thinning in Parkinson disease. Archives of Ophthalmology (Chicago, Ill. : 1960). 127: 737-41. PMID 19506190 DOI: 10.1001/archophthalmol.2009.106 |
0.247 |
|
1979 |
Bodis-Wollner I. Visual implications of diagnostic advances in neurology. Journal of the American Optometric Association. 50: 89-92. PMID 762379 |
0.247 |
|
1983 |
Atkin A, Bodis-Wollner I, Podos SM, Wolkstein M, Mylin L, Nitzberg S. Flicker threshold and pattern VEP latency in ocular hypertension and glaucoma. Investigative Ophthalmology & Visual Science. 24: 1524-8. PMID 6642932 |
0.243 |
|
1978 |
Bender MB, Bodis-Wollner I. Visual dysfunctions in optic tract lesions. Annals of Neurology. 3: 187-93. PMID 666260 DOI: 10.1002/ana.410030302 |
0.24 |
|
2013 |
Bodis-Wollner I, Antal A. Primary Visual and Visuocognitive Deficits Milestones in Drug Therapy. 24: 317-334. DOI: 10.1007/978-1-60761-429-6_22 |
0.239 |
|
1989 |
Bobak P, Bodis-Wollner I, Guillory S, Anderson R. Aging differentially delays visual evoked potentials to checks and gratings Clinical Vision Sciences. 4: 269-274. |
0.237 |
|
1991 |
Aminoff MJ, Bodis-Wollner I, Chatrian GE, Chiappa KH, Emerson RG, Grundy BL, Klem GR, Legatt AD, Matsumiya Y, Rowe MJ, Streletz LJ, Yamada T. American electroencephalographic society guidelines for writing clinical evoked potential reports Journal of Clinical Neurophysiology. 8: 85-87. PMID 2019652 DOI: 10.1097/00004691-199101000-00010 |
0.235 |
|
1974 |
Bodis-Wollner I. On dissociated visual functions. The Mount Sinai Journal of Medicine, New York. 41: 38-45. PMID 4592832 |
0.234 |
|
1984 |
Atkin A, Bodis-Wollner I, Wolkstein M, Podos S. Contrast sensitivity testing. The British Journal of Ophthalmology. 68: 63-4. PMID 6689937 DOI: 10.1136/Bjo.68.1.63 |
0.233 |
|
2015 |
Slotnick S, Ding Y, Glazman S, Durbin M, Miri S, Selesnick I, Sherman J, Bodis-Wollner I. A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1692-5. PMID 26340519 DOI: 10.1002/Mds.26411 |
0.232 |
|
2013 |
Adam C, Shrier E, Glazman S, Bodis-Wollner I. Decreased Contrast Sensitivity and inner retinal thinning of the fovea in Parkinson Disease Basal Ganglia. 3: 50-51. DOI: 10.1016/j.baga.2013.01.032 |
0.231 |
|
1988 |
Waksman BH, Bodis-Wollner I. Annual Meeting, Association for Research in Nervous and Mental Diseases Inc: Immunologic Mechanisms in Neurologic and Psychiatric Disease Archives of Neurology. 45: 1279-1283. DOI: 10.1001/Archneur.1988.00520350116028 |
0.231 |
|
2013 |
Bodis-Wollner I, Ding A, Shrier E, Selesnick I, Glazman S. Asymmetry of the retina in the two eyes in Parkinson Disease Basal Ganglia. 3: 50. DOI: 10.1016/J.Baga.2013.01.031 |
0.229 |
|
1982 |
Bodis-Wollner I, Onofrj M. System diseases and visual evoked potential diagnosis in neurology: changes due to synaptic malfunction. Annals of the New York Academy of Sciences. 388: 327-48. PMID 6283999 DOI: 10.1111/j.1749-6632.1982.tb50800.x |
0.229 |
|
1979 |
Bodis-Wollner I, Hendley CD, Mylin LH, Thornton J. Visual evoked potentials and the visuogram in multiple sclerosis. Annals of Neurology. 5: 40-7. PMID 426467 DOI: 10.1002/ana.410050107 |
0.229 |
|
2002 |
Bodis-Wollner I, von Gizycki H, Amassian V, Avitable M, Mari Z, Hallett M, Bucher S, Hussain Z, Lalli S, Cracco R. The dynamic effect of saccades in the visual cortex: evidence from fMRI, sTMS and EEG studies International Congress Series. 1232: 843-851. DOI: 10.1016/S0531-5131(01)00676-8 |
0.228 |
|
1996 |
Bodis-Wollner I, Kleiner L. Spatial summation in the paracentral visual field in carriers of Leber's hereditary optic neuropathy Investigative Ophthalmology and Visual Science. 37: S922. |
0.228 |
|
1986 |
Bodis-Wollner I. The visual system, MBL lectures in biology, volume 5 Survey of Ophthalmology. 30: 402-403. DOI: 10.1016/0039-6257(86)90095-0 |
0.225 |
|
1990 |
Bodis-Wollner I, Mylin L, Ghilardi M. The diagnostic significance of the topography of N70 of the VEP Electroencephalography and Clinical Neurophysiology. 75: S12. DOI: 10.1016/0013-4694(90)91761-D |
0.22 |
|
2017 |
Gibbons CH, Simon DK, Huang M, Tilley B, Aminoff MJ, Bainbridge JL, Brodsky M, Freeman R, Goudreau J, Hamill RW, Luo ST, Singer C, Videnovic A, Bodis-Wollner I, Wong PS, et al. Autonomic and electrocardiographic findings in Parkinson's disease. Autonomic Neuroscience : Basic & Clinical. PMID 28506500 DOI: 10.1016/J.Autneu.2017.04.002 |
0.22 |
|
2008 |
Forgacs PB, von Gizycki H, Selesnick I, Syed NA, Ebrahim K, Avitable M, Amassian V, Lytton W, Bodis-Wollner I. Perisaccadic parietal and occipital gamma power in light and in complete darkness. Perception. 37: 419-32. PMID 18491719 DOI: 10.1068/P5875 |
0.218 |
|
2021 |
Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, ... ... Bodis-Wollner I, et al. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. Jama. 326: 926-939. PMID 34519802 DOI: 10.1001/jama.2021.10207 |
0.214 |
|
1998 |
Antal A, Bandini F, Keri S, Bodis-Wollner I. Gastrointestinal dysfunction in Parkinson's disease Clinical Neuroscience. 5: 136-146. PMID 10785840 |
0.212 |
|
1999 |
Antal A, Kéri S, Bodis-Wollner I. L-alpha-glycerylphosphorylcholine enhances the amplitude of the pattern electroretinogram in rhesus monkeys. A pilot study. Neurobiology (Budapest, Hungary). 7: 407-12. PMID 10897800 |
0.211 |
|
2006 |
Lalli S, Hussain Z, Ayub A, Cracco RQ, Bodis-Wollner I, Amassian VE. Role of the calcarine cortex (V1) in perception of visual cues for saccades. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 117: 2030-8. PMID 16884952 DOI: 10.1016/j.clinph.2006.05.022 |
0.211 |
|
2002 |
Sherman J, Sadun A, Bodis-Wollner I. IFOND SPONSORED INTERNATIONAL FIELD INVESTIGATION OF A 300 MEMBER PEDIGREE WITH LHON IN BRAZIL. Optometry and Vision Science. 79: 20. DOI: 10.1097/00006324-200212001-00033 |
0.206 |
|
1979 |
Bodis-Wollner I, Hendley CD. On the separability of two mechanisms involved in the detection of grating patterns in humans. The Journal of Physiology. 291: 251-63. PMID 480212 DOI: 10.1113/jphysiol.1979.sp012810 |
0.204 |
|
2005 |
Antal A, Bodis-Wollner I, Paulus W. Chapter 25 Visual dysfunction in disorders with altered dopaminergic neurotransmission Handbook of Clinical Neurophysiology. 5: 467-490. DOI: 10.1016/S1567-4231(09)70222-9 |
0.204 |
|
2013 |
He BJ, Nolte G, Nagata K, Takano D, Yamazaki T, Fujimaki Y, Maeda T, Satoh Y, Heckers S, George MS, Lopes da Silva F, de Munck JC, Van Houdt PJ, Verdaasdonk RM, Ossenblok P, ... ... Bodis-Wollner I, et al. Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013. Clinical Eeg and Neuroscience. PMID 24368763 DOI: 10.1177/1550059413507209 |
0.203 |
|
1991 |
OâBrien CP, Bodis-Wollner I, Westheimer O. Conference abstracts: “advances in understanding the addictive states” Advances in Alcohol and Substance Abuse. 9: 133-141. DOI: 10.1300/J251V09N03_10 |
0.202 |
|
2008 |
Rieger J, Kim A, Argyelan M, Farber M, Glazman S, Liebeskind M, Bodis-Wollner I. Cortical control of voluntary saccades in Parkinson's Disease Klinische Neurophysiologie. 39. DOI: 10.1055/S-2008-1073011 |
0.197 |
|
2014 |
Bodis-Wollner I, Miri S, Glazman S. Venturing into the no-man's land of the retina in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 15-22. PMID 24339212 DOI: 10.1002/mds.25741 |
0.191 |
|
2008 |
Amassian V, Mari Z, Sagliocco L, Hassan N, Maccabee P, Cracco JB, Cracco RQ, Bodis-Wollner I. Perception of phosphenes and flashed alphabetical characters is enhanced by single-pulse transcranial magnetic stimulation of anterior frontal lobe: the thalamic gate hypothesis. Perception. 37: 375-88. PMID 18491715 DOI: 10.1068/p5948 |
0.188 |
|
1987 |
Onofrj M, Ghilardi MF, Faricelli A, Bodis-Wollner I, Calvani M. Effect of levo-acetylcarnitine on P300-like potentials of the normal monkey. Drugs Under Experimental and Clinical Research. 13: 407-15. PMID 3652929 |
0.186 |
|
1984 |
Bodis-Wollner I, Yahr MD, Mylin LH. Nonmotor functions of the basal ganglia. Advances in Neurology. 40: 289-98. PMID 6695605 |
0.184 |
|
2006 |
Balazs S, Stepan C, Binder H, von Gizycki H, Avitable M, Obersteiner A, Rattay F, Selesnick I, Bodis-Wollner I. Conjugate eye movements and gamma power modulation of the EEG in persistent vegetative state. Journal of the Neurological Sciences. 246: 65-9. PMID 16580696 DOI: 10.1016/J.Jns.2006.02.007 |
0.182 |
|
1992 |
Bodis-Wollner I. Sensory evoked potentials: PERG, VEP, and SEP. Current Opinion in Neurology and Neurosurgery. 5: 716-26. PMID 1392145 |
0.174 |
|
2013 |
Pfeiffer RF, Bodis-Wollner I. Parkinson's Disease and Nonmotor Dysfunction Current Clinical Neurology. 24. DOI: 10.1007/978-1-60761-429-6 |
0.17 |
|
2014 |
Wu B, Hu X, Wang X, Bodis-Wollner I. Effects of subthalamic nucleus deep brain stimulation on cognitive function in patients with Parkinson's disease Chinese Journal of Neurology. 47: 617-623. DOI: 10.3760/cma.j.issn.1006-7876.2014.09.005 |
0.167 |
|
1997 |
Bodis-Wollner I. Vision and neurodegenerative diseases. Vision Research. 37: 3441-3. PMID 9425520 |
0.163 |
|
1991 |
Bodis-Wollner I, Chung E, Ghilardi MF, Glover A, Onofrj M, Pasik P, Samson Y. Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 3: 63-72. PMID 2064731 DOI: 10.1007/BF02251137 |
0.152 |
|
2008 |
Bodis-Wollner I. Pre-emptive perception. Perception. 37: 462-78. PMID 18491722 DOI: 10.1068/p5880 |
0.151 |
|
2015 |
Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, et al. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. Jama. 313: 584-93. PMID 25668262 DOI: 10.1001/Jama.2015.120 |
0.151 |
|
2015 |
Bega D, Luo S, Fernandez H, Chou K, Aminoff M, Parashos S, Walker H, Russell DS, Christine CW, Dhall R, Singer C, Bodis-Wollner I, Hamill R, Truong D, Mari Z, et al. Impact of Depression on Progression of Impairment and Disability in Early Parkinson's Disease. Movement Disorders Clinical Practice. 2: 371-378. PMID 28393083 DOI: 10.1002/Mdc3.12205 |
0.151 |
|
1991 |
Brannan JR, Bodis-Wollner I. Evidence for two systems mediating perceived contrast. Visual Neuroscience. 6: 587-92. PMID 1883763 DOI: 10.1017/S0952523800002571 |
0.149 |
|
1996 |
Bodis-Wollner I. Electrophysiological assessment of retinal dopaminergic deficiency. Electroencephalography and Clinical Neurophysiology. Supplement. 46: 35-41. PMID 9059777 |
0.143 |
|
1993 |
Antal A, Bodis-Wollner I. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview. Neurobiology (Budapest, Hungary). 1: 101-22. PMID 8111350 |
0.142 |
|
1976 |
Bodis-Wollner IG, Pollen DA, Ronner SF. Responses of complex cells in the visual cortex of the cat as a function of the length of moving slits. Brain Research. 116: 205-16. PMID 974772 DOI: 10.1016/0006-8993(76)90900-8 |
0.136 |
|
1995 |
Bodis-Wollner I, Antal A. On the functional significance of primate retinal dopamine receptors. Journal of Neural Transmission. Supplementum. 45: 67-74. PMID 8748611 |
0.134 |
|
1972 |
Bodis-Wollner I. Contrast sensitivity and increment threshold. Perception. 1: 73-83. PMID 4680927 DOI: 10.1068/p010073 |
0.133 |
|
1990 |
Bodis-Wollner I. Physiological effects of acetyl-levo-carnitine in the central nervous system. International Journal of Clinical Pharmacology Research. 10: 109-14. PMID 2201653 |
0.132 |
|
2012 |
Bodis-Wollner I, Tzelepi A. The Effect of Diverse Dopamine Receptors on Spatial Processing in the Central Retina: A Model Seeing Spatial Form. DOI: 10.1093/acprof:oso/9780195172881.003.0017 |
0.121 |
|
1990 |
Lustgarten JS, Marx MS, Podos SM, Bodis-Wollner I, Campeas D, Serle JB. Contrast sensitivity and computerized perimetry in early detection of glaucomatous change Clinical Vision Sciences. 5: 407-413. |
0.121 |
|
1990 |
Rubin GS, Bodis-Wollner I, Bullock JD, Holladay JT, Jaffe GF, Koch D, Lempert P, Mannis MJ, Marmor MF, Masket S, Miller D, Neumann AC, Regan DM, Richburg FA, Slonim CB, et al. Contrast sensitivity and glare testing in the evaluation of anterior segment disease Ophthalmology. 97: 1233-1237. PMID 2234858 DOI: 10.1016/s0161-6420(90)32431-4 |
0.12 |
|
1987 |
Onofrj M, Bodis-Wollner I, Calvani M. Effect of L-acetyl carnitine HCl on rat steady-state visual evoked potentials. Comparison with L-carnitine. Drugs Under Experimental and Clinical Research. 13: 5-13. PMID 3595444 |
0.115 |
|
2010 |
Bodis-Wollner I. WS7-1 Saccade-related cortical activity Clinical Neurophysiology. 121: S80. DOI: 10.1016/S1388-2457(10)60339-2 |
0.109 |
|
1985 |
Bodis-Wollner I. Progress in retinal research, volume 3 Survey of Ophthalmology. 30: 203-204. DOI: 10.1016/0039-6257(85)90064-5 |
0.109 |
|
1997 |
Bodis-Wollner I. Neurodegenerative disease and optic neuropathy; the MPTP lesson Investigative Ophthalmology and Visual Science. 38: S246. |
0.108 |
|
1996 |
Bucher SF, Seelos KC, Bodis-Wollner I, Paulus W, Oertel WH, Reiser M. High resolution cortical activation mapping of voluntary eye movements using functional magnetic resonance imaging. Electroencephalography and Clinical Neurophysiology. Supplement. 47: 253-8. PMID 9335989 |
0.108 |
|
1980 |
Bodis-Wollner I. PATTERN ELECTRORETINOGRAMS: GENERAL DISCUSSION Annals of the New York Academy of Sciences. 338: 602-607. DOI: 10.1111/j.1749-6632.1980.tb19384.x |
0.104 |
|
1987 |
Celesia GG, Allison T, Bodis-Wollner I, Chatrian GE, Chiappa KH, Coats A, Cracco JB, Davis S, Grundy B, Matsumiya Y, Meng E, Raudzens P, Nuwer MR. American electroencephalographic society guidelines for intraoperative monitoring of sensory evoked potentials Journal of Clinical Neurophysiology. 4: 397-416. PMID 3680496 |
0.101 |
|
1989 |
Bodis-Wollner I, Marx MS, Ghilardi MF. Systemic haloperidol administration increases the amplitude of the light- and dark-adapted flash ERG in the monkey Clinical Vision Sciences. 4: 19-26. |
0.1 |
|
1997 |
Bodis-Wollner I. How the size of the stimulus determines simultaneous PERG and VEP responses: What you gain and what you lose in the transit Electroencephalography and Clinical Neurophysiology. 103: 20. DOI: 10.1016/s0013-4694(97)87995-7 |
0.1 |
|
1996 |
Ghosh SS, Fahy E, Bodis-Wollner I, Sherman J, Howell N. Longitudinal study of a heteroplasmic 3460 Leber hereditary optic neuropathy family by multiplexed primer-extension analysis and nucleotide sequencing. American Journal of Human Genetics. 58: 325-34. PMID 8571959 |
0.099 |
|
1996 |
Mari Z, Sagliocco L, Bodis-Wollner I. Pattern adaptation affects the phase of the PERG Investigative Ophthalmology and Visual Science. 37: S346. |
0.097 |
|
2002 |
Bodis-Wollner I, Von Gizycki H, Avitable M, Hussain Z, Javeid A, Habib A, Raza A, Sabet M. Perisaccadic occipital EEG changes quantified with wavelet analysis. Annals of the New York Academy of Sciences. 956: 464-7. PMID 11960841 |
0.092 |
|
2006 |
Forgacs PB, Von Gizycki H, Harhula M, Avitable M, Selesnick I, Bodis-Wollner I. Chapter 25 The wavelet transformed EEG: a new method of trial-by-trial evaluation of saccade-related cortical activity Supplements to Clinical Neurophysiology. 59: 183-189. DOI: 10.1016/S1567-424X(09)70029-7 |
0.091 |
|
2010 |
Bodis-Wollner I. S40-5 Perisaccadic modulation of brain activity: EEG and fMRI Clinical Neurophysiology. 121: S60. DOI: 10.1016/S1388-2457(10)60252-0 |
0.087 |
|
2008 |
Bodis-Wollner I. Pre-emptive perception. Introduction. Perception. 37: 330-2. PMID 18491711 |
0.086 |
|
2008 |
Bodis-Wollner I. Perception: Introduction Perception. 37: 330-332. |
0.083 |
|
1998 |
Bodis-Wollner I, Fukuda Y, Spekreijse H, Wu SM. First Annual Conference in Association with Vision Research, 9-10 May 1997: Molecular, cellular and genetic approaches to function and dysfunction of the retina Vision Research. 38: 1313-1314. DOI: 10.1016/S0042-6989(98)00115-1 |
0.076 |
|
2006 |
Balazs S, Bodis-Wollner I, Binder H. P21.4 Gamma EEG in the evaluation of persistent vegetative state Clinical Neurophysiology. 117: 217-218. DOI: 10.1016/j.clinph.2006.06.416 |
0.076 |
|
1997 |
Bodis-Wollner I. Optic nerve disease: an introduction. Clinical Neuroscience (New York, N.Y.). 4: 213-5. PMID 9292246 |
0.075 |
|
1973 |
Bodis-Wollner I, Diamond SP. A method of testing and evaluating blurred vision in cerebral lesions. Transactions of the American Neurological Association. 98: 57-60. PMID 4784975 |
0.067 |
|
1992 |
Howell N, McCullough D, Bodis-Wollner I. Molecular genetic analysis of a sporadic case of Leber hereditary optic neuropathy. American Journal of Human Genetics. 50: 443-6. PMID 1734726 |
0.04 |
|
1998 |
Bodis-Wollner I, Pfeiffer RF. Clinical neuroscience: Introduction Clinical Neuroscience. 5: 61-62. |
0.039 |
|
1991 |
O'Brien CP, Bodis-Wollner I, Westheimer O. Conference Abstracts: Advances in Alcohol & Substance Abuse. 9: 133-141. DOI: 10.1300/J251v09n03_10 |
0.039 |
|
1982 |
Bodis-Wollner I, Onofrj M, Mylin LH. VEP recovery in treated B12 deficiency Neurology. 32: A 204. |
0.037 |
|
1967 |
Auerswald W, Bodis-Wollner I, Kiesewetter E, Mickerts D, Speiser P. [On the problem of antibody formation against Gm in adults following repeated parenteral administration of homologous gamma globulin]. Wiener Medizinische Wochenschrift (1946). 117: 1006-8. PMID 4173601 |
0.017 |
|
1994 |
Howell N, Xu M, Halvorson S, Bodis-Wollner I, Sherman J. A heteroplasmic LHON family: tissue distribution and transmission of the 11778 mutation. American Journal of Human Genetics. 55: 203-6. PMID 8023847 |
0.015 |
|
2013 |
Pfeiffer RF, Bodis-Wollner I. Preface Current Clinical Neurology. 24: ix-xi. |
0.01 |
|
2001 |
Bodis-Wollner I. The re-emergence of systems neuroscience Clinical Eeg Electroencephalography. 32: 96-97. DOI: 10.1177/155005940103200303 |
0.01 |
|
1997 |
Pfeiffer RE, Bodis-Wollner I. In reply Journal of the American Geriatrics Society. 45: 894-895. PMID 9215350 DOI: 10.1111/j.1532-5415.1997.tb01527.x |
0.01 |
|
1996 |
Pfeiffer RF, Bodis-Wollner I. Charles Bonnet syndrome. Journal of the American Geriatrics Society. 44: 1128-9. PMID 8790248 DOI: 10.1111/j.1532-5415.1996.tb02955.x |
0.01 |
|
1990 |
Bodis-Wollner I, Hess RF, Zrenner E. Editorial Clinical Vision Sciences. 5: i. |
0.01 |
|
Hide low-probability matches. |